These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31357134)

  • 1. BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis.
    Vernaci G; Dieci MV; Manfrin S; Mantiero M; Falci C; Faggioni G; Mioranza E; Menichetti A; Tasca G; Griguolo G; Miglietta F; Di Liso E; Saibene T; Michieletto S; Ghiotto C; Conte P; Guarneri V
    Breast; 2019 Oct; 47():77-84. PubMed ID: 31357134
    [No Abstract]   [Full Text] [Related]  

  • 2. Does obesity have an effect on outcomes in triple-negative breast cancer?
    Mowad R; Chu QD; Li BD; Burton GV; Ampil FL; Kim RH
    J Surg Res; 2013 Sep; 184(1):253-9. PubMed ID: 23768767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
    van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
    Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is obesity an independent prognosis factor in woman breast cancer?
    Majed B; Moreau T; Senouci K; Salmon RJ; Fourquet A; Asselain B
    Breast Cancer Res Treat; 2008 Sep; 111(2):329-42. PubMed ID: 17939036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
    Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
    BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
    Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
    Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of body mass index in locally advanced breast cancer.
    Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Islam R; Hortobagyi GN; Cristofanilli M
    Clin Cancer Res; 2008 Mar; 14(6):1718-25. PubMed ID: 18347172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
    Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
    J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence dynamics of breast cancer according to baseline body mass index.
    Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
    Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.
    Crispo A; Grimaldi M; D'Aiuto M; Rinaldo M; Capasso I; Amore A; D'Aiuto G; Giudice A; Ciliberto G; Montella M
    Breast; 2015 Feb; 24(1):86-9. PubMed ID: 25466863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.
    Bastarrachea J; Hortobagyi GN; Smith TL; Kau SW; Buzdar AU
    Ann Intern Med; 1994 Jan; 120(1):18-25. PubMed ID: 8250452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the obesity on lymph node status in operable breast cancer patients.
    Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
    J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
    Hyun SH; Ahn HK; Lee JH; Choi JY; Kim BT; Park YH; Im YH; Lee JE; Nam SJ; Lee KH
    PLoS One; 2016; 11(10):e0165814. PubMed ID: 27798667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of body mass index on disease-free and overall survival in Chinese women with breast cancer].
    Zhang Y; Qu Q; Mao Y; Shen K
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):395-9. PubMed ID: 26463035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of overweight with breast cancer survival.
    Tao MH; Shu XO; Ruan ZX; Gao YT; Zheng W
    Am J Epidemiol; 2006 Jan; 163(2):101-7. PubMed ID: 16339054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
    Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
    Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
    Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
    Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
    Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
    Chung IY; Lee JW; Lee JS; Park YR; Min YH; Lee Y; Yoon TI; Sohn G; Lee SB; Kim J; Kim HJ; Ko BS; Son BH; Ahn SH
    PLoS One; 2017; 12(3):e0170311. PubMed ID: 28248981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.